Personalized Medicine Expert Gains Prominent FDA Role In Agency Reorg
This article was originally published in The Gray Sheet
Commissioner Margaret Hamburg’s reorganization at the top of FDA puts an expert in pediatric drug development and pharmacogenomics in a new post overseeing four of the seven agency centers, including the device unit.
You may also be interested in...
The winning candidate would be the third to hold the position in two years. The job notice will be corrected, though – top secret clearance is not required.
Energy and Commerce Committee letter states public information discrepancies raised questions about Leona Brenner-Gati’s status and “the circumstances surrounding her resignation.”
Former J&J executive Leona Brenner-Gati will become acting deputy commissioner for medical products and tobacco following the departure of Stephen Spielberg.